Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years.

Autor:	Biscaldi, Lauren
Zdroj:	Drug Topics. May2024, Vol. 168 Issue 4, p10-10. 1p.
Databáze:	Business Source Ultimate
Externí odkaz:	Zobrazit plný text záznamu